MO Stock Dividend 2026: Altria's $1.06 Quarterly, 55-Year King Streak & Is It Sustainable?
Altria Group (NYSE: MO) is one of the most debated — and most rewarding — dividend stocks in the U.S. market. The maker of Marlboro cigarettes pays a quarterly dividend of $1.06 per share, equating to an annualized rate of approximately $4.24 per share and a trailing dividend yield of roughly 6%–7% — one of the highest yields among large-cap U.S. stocks outside of the REIT and utilities sectors.
More remarkably, Altria has increased its annual dividend for more than 55 consecutive years — well beyond the 50-year threshold required to qualify as a Dividend King, the most elite dividend longevity designation in U.S. equity markets. Altria has been described as making 60 dividend increases over the past 56 years — including years where it raised the dividend twice.
But MO's extraordinary yield and streak come with equally extraordinary complexity: the 2008 Philip Morris International spinoff, the catastrophic $12.8 billion JUUL investment, the ongoing pivot to smokeless nicotine products, and the existential question of what declining cigarette volumes mean for long-term dividend growth. This guide covers all of it — in depth.
MO Dividend Snapshot (Current Data)
All figures below are based on publicly available data as of early 2026. Verify current values at investor.altria.com.
| Metric | Current Value | Notes |
|---|---|---|
| Quarterly Dividend Per Share | $1.06 | Increased from $1.02 in Q3 2025 |
| Annual Dividend Per Share (est.) | ~$4.24 | $1.06 × 4 quarters (annualized at current rate) |
| Trailing Dividend Yield (TTM) | ~6%–7% | Varies with MO share price; one of the highest in the S&P 500 |
| Payment Frequency | Quarterly | Jan, Apr, Jul, Oct payment months |
| Stock Ticker & Exchange | MO — NYSE | Altria Group, Inc. |
| Sector / Industry | Consumer Staples — Tobacco | Primarily domestic U.S. tobacco (Marlboro) |
| Consecutive Dividend Increases | 55+ years | 60 increases over 56 years per Altria; see PM spinoff note |
| Dividend King Status | Yes ✅ | Qualifies for 50+ consecutive years of annual increases |
| Dividend Aristocrat Status | Yes ✅ | Also qualifies for Aristocrat (25+ years) |
| Adjusted EPS Payout Ratio | ~78%–82% | Based on Altria's adjusted (non-GAAP) EPS; sustainable for tobacco sector |
| GAAP Payout Ratio (TTM) | ~100%+ | Inflated by JUUL/impairment charges; not representative of cash dividend coverage |
| Credit Rating (S&P) | BBB (stable) | Investment grade; lower than energy majors due to tobacco secular risk |
The GAAP payout ratio appearing above 100% reflects large non-cash impairment charges (primarily JUUL writedowns) rather than cash flow available for dividends. Altria's adjusted EPS-based payout ratio (~78–82%) and strong free cash flow generation are the more relevant sustainability metrics. See Section 7 for full analysis.
Altria as a Dividend Stock: Business Model
Altria is the dominant manufacturer of cigarettes in the United States, operating primarily through its Philip Morris USA subsidiary — which markets the Marlboro brand, the best-selling cigarette in the U.S. by a significant margin. Despite decades of declining cigarette volumes (adult U.S. smokers have fallen from more than 40% of adults in the 1960s to approximately 11–12% today), Altria has sustained and grown its dividend through a combination of:
- Pricing power: Altria consistently raises Marlboro prices faster than volume declines, partially offsetting the revenue impact of fewer cigarettes sold. This pricing model — unique to a product with inelastic demand and high brand loyalty — is the core engine of MO's dividend durability.
- Cost discipline and margin expansion: Altria has systematically reduced its cost base as volumes decline, protecting per-unit profitability and sustaining high free cash flow conversion from its tobacco business.
- Smokeless & oral nicotine diversification: Through its U.S. Smokeless Tobacco Company (USSTC) division, Altria sells Copenhagen, Skoal, and other moist smokeless tobacco brands. Its "on!" nicotine pouch brand has grown rapidly, and the NJOY e-vapor acquisition (2023) represents Altria's largest bet on smoke-free alternatives after writing off the failed JUUL investment.
One critical distinction for dividend investors: Altria's operations are entirely domestic U.S. following the 2008 spinoff of Philip Morris International (PM). This means Altria's dividend does not benefit from international growth markets — but also means no currency exchange rate exposure, a simplification that many income investors appreciate.
To understand how MO's yield compares to the broader universe of high-yield dividend payers, see our highest dividend yield stocks guide.
Altria's Dividend King Status: 55+ Year Streak Explained
Altria holds Dividend King status — one of fewer than 50 U.S. companies to have raised its annual dividend for 50 or more consecutive years. This places MO in elite company alongside Procter & Gamble, Coca-Cola, Johnson & Johnson, and 3M among others.
Dividend King vs. Aristocrat: The Distinction
| Designation | Requirement | MO Qualifies? | Index / ETF |
|---|---|---|---|
| Dividend Aristocrat | S&P 500 member + 25+ consecutive years of increases | Yes ✅ | NOBL ETF (ProShares S&P 500 Dividend Aristocrats) |
| Dividend King | 50+ consecutive years of dividend increases (any exchange) | Yes ✅ | SDOG, KNG ETFs and various "Dividend Kings" screeners |
MO's 55+ year streak is particularly striking given that it includes the 2008 spinoff of Philip Morris International — an event that some analysts argue should reset the streak clock. See Section 5 for the full explanation of why most dividend databases continue to credit Altria's pre-spinoff history toward its consecutive increases count.
For a complete ranking of Dividend Kings and Aristocrats across all sectors, see our Dividend Aristocrats list and guide.
MO Dividend History (2018–2025)
Altria typically announces dividend increases twice per year — in July (Q3) and January (Q1). The table below shows each annual cycle's starting quarterly rate and estimated annual total.
| Year | Starting Quarterly Rate | Annual Total (est.) | YoY Increase | Key Events |
|---|---|---|---|---|
| 2018 | $0.80 | ~$3.20 | ~14% | JUUL stake acquired ($12.8B, Dec 2018); strong tobacco FCF underpins raise |
| 2019 | $0.84 | ~$3.36 | ~5% | First JUUL writedown; regulatory scrutiny on e-vapor; dividend still raised |
| 2020 | $0.86 | ~$3.44 | ~2% | COVID-19; JUUL writedowns continue; slowest increase in decades |
| 2021 | $0.90 | ~$3.60 | ~5% | Recovery; Marlboro pricing power offsets volume decline; JUUL saga continues |
| 2022 | $0.94 | ~$3.76 | ~4% | JUUL near-total writedown; dividend maintained; litigation headwinds |
| 2023 | $0.94→$0.98 | ~$3.84 | ~4% | NJOY e-vapor acquisition ($2.75B); "on!" pouch growth; div raised mid-year |
| 2024 | $0.98→$1.02 | ~$4.00 | ~4% | Smokeless segment growth; Marlboro pricing holding; 54th consecutive annual increase |
| 2025 | $1.02→$1.06 | ~$4.16 | ~4% | "on! PLUS" FDA authorized (Dec 2025); NJOY integrating; 55th consecutive annual increase |
Altria typically raises the quarterly dividend twice annually (January and July cycles), so annual totals are approximated. Verify the complete official history at investor.altria.com.
The Philip Morris International Spinoff: Does It Break Altria's Dividend Streak?
This is one of the most commonly misunderstood aspects of Altria's dividend history. On March 28, 2008, Altria spun off its international tobacco operations as a separate publicly traded company: Philip Morris International (NYSE: PM). Each Altria shareholder received one PM share for every Altria share held. After the spinoff:
- Altria's annual dividend was reduced from $3.00 (pre-spinoff, representing the combined company) to approximately $1.68 (post-spinoff, representing only the remaining U.S. operations).
- The total income to shareholders who held both stocks was effectively preserved — the combined dividends of MO + PM equaled approximately what MO alone paid pre-spinoff.
Why Dividend Databases Credit the Streak
The key question is: did Altria "cut" its dividend in 2008? By strict dollar-per-share measurement, the per-share rate dropped after the spinoff. However, most dividend tracking databases — including S&P Dow Jones (the Aristocrat list administrator) and major dividend research platforms — credit Altria's pre-2008 history toward its consecutive increase streak because:
- The per-share reduction was a mechanical consequence of a proportionate corporate restructuring (the company's equity was split), not a choice to distribute less cash to shareholders.
- S&P's Aristocrat criteria has specific provisions for spinoffs and special dividends that distinguish them from outright cuts.
- The immediate post-spinoff dividend rate was still higher in real terms to shareholders when counted as MO + PM combined.
Investors who want exposure to Philip Morris International's international tobacco markets and a separately grown dividend record should note that PM has grown its dividend independently since 2008. Both MO and PM are considered separately for dividend tracking purposes post-spinoff.
MO Ex-Dividend Dates & Payment Schedule 2025
Altria pays dividends quarterly. The ex-dividend dates typically fall in March, June, September, and December, with payment in the following month. Always verify at investor.altria.com.
| Quarter | Amount Per Share | Ex-Dividend Date | Pay Date |
|---|---|---|---|
| Q1 2025 | $1.02 | March 25, 2025 | April 30, 2025 |
| Q2 2025 | $1.06 | June 16, 2025 | July 10, 2025 |
| Q3 2025 | $1.06 | September 15, 2025 | October 10, 2025 |
| Q4 2025 | $1.06 | December 26, 2025 | January 9, 2026 |
Note that Altria raised the quarterly dividend from $1.02 to $1.06 during Q2 2025. Q1 2025 was the last quarter paid at the prior $1.02 rate. Always verify ex-dividend and payment dates at investor.altria.com or your brokerage's dividend calendar.
How to Qualify for an MO Dividend
You must purchase and hold MO shares before (not on or after) the ex-dividend date to receive the declared quarterly payment. With U.S. equity settlement at T+1, purchasing the day before the ex-date is sufficient. Altria offers a Dividend Reinvestment Plan (DRIP) through Computershare, with options for full or partial reinvestment of quarterly dividends into additional MO shares.
Is MO's Dividend Sustainable? Payout Ratio & FCF Analysis
Altria's dividend sustainability debate has two entirely different conversations depending on which payout ratio you're looking at — and which time horizon you're evaluating.
GAAP vs. Adjusted EPS Payout Ratio: The JUUL Distortion
Altria's GAAP payout ratio has periodically exceeded 100%, which appears alarming. However, this is almost entirely driven by non-cash impairment charges — most notably the progressive writedown of Altria's $12.8 billion stake in JUUL Labs. By December 2018, Altria acquired a 35% equity stake in JUUL at a valuation of $38 billion. By 2022, the investment was worth approximately 5% of its original value following regulatory action, a consent agreement limiting JUUL's market activities, and JUUL's own financial distress.
These impairment charges reduced Altria's GAAP earnings per share dramatically in impacted years — but they do not represent cash leaving the company. Altria's actual cash generation from its tobacco and smokeless businesses remained strong throughout this period. The more meaningful metric is the adjusted (non-GAAP) EPS payout ratio — which Altria itself targets at approximately 78–82% of adjusted EPS. At this level, the dividend is well-covered by operating earnings, and Altria generates roughly $8–9 billion in annual operating cash flow from its businesses.
Free Cash Flow: The Real Foundation
Altria's tobacco business generates exceptionally high free cash flow conversion — cigarette manufacturing has low ongoing capital expenditure requirements relative to revenue. Total annual dividends paid are approximately $7–8 billion versus an operating cash flow that has historically ranged from $8–10 billion, yielding an FCF-based payout ratio that is generally sustainable for the medium term.
The Volume Decline Problem: Long-Term Headwind
The more legitimate sustainability concern is not whether dividends are covered today, but whether they can remain covered as cigarette shipment volumes inevitably decline. Altria has been offsetting volume declines through price increases — but pricing power has limits, and as the smoker population shrinks, even aggressive pricing cannot indefinitely sustain a stable or growing revenue base. The transition to smokeless products (oral nicotine, e-vapor via NJOY) is critical but uncertain in how quickly it can replace combustible cigarette economics.
MO vs. PM vs. BTI: Tobacco Dividend Peer Comparison
Tobacco companies are among the highest-yielding dividend payers in the market. Here's how Altria compares to its major peers:
| Company | Ticker | Annual Div (est.) | Yield (approx.) | Streak | King/Aristocrat? | Geography |
|---|---|---|---|---|---|---|
| Altria Group | MO | ~$4.24 | ~6%–7% | 55+ years | King + Aristocrat ✅ | U.S. only |
| Philip Morris International | PM | ~$5.28 | ~4%–5% | ~16 years (since 2008 spinoff) | Aristocrat eligible in progress | International (ex-U.S.) |
| British American Tobacco | BTI | ~$2.80–3.20 | ~8%–10% | Cut history; reset post-2023 | No ❌ | International + U.S. |
BTI pays dividends in GBP (ADR converts to USD); figures are approximate USD equivalents and may vary with exchange rates. BTI's high yield partly reflects a dividend reduction and market discount applied to UK-listed tobacco stocks. PM was spun off from Altria in 2008 and tracks its own dividend history independently since then. All yields are approximate and depend on prevailing share prices — verify current data at each company's investor relations page.
MO vs. PM: Which Tobacco Dividend Is Better?
MO and PM are natural comparisons — they were one company until 2008. Post-spinoff, the differences are substantial: MO offers a higher current yield (~6–7%), Dividend King status, and no currency exposure but is limited to declining U.S. cigarette volumes with smokeless diversification still maturing. PM benefits from global emerging market tobacco growth (particularly in Asia and Africa), its IQOS heated tobacco platform which is growing rapidly, and the acquisition of Swedish Match (oral nicotine/snus). PM's yield is lower (~4–5%) but its growth prospects for both earnings and dividend per share are generally considered stronger than Altria's.
Income investors who want both global diversification and domestic yield often hold both MO and PM. For a broader view of top dividend payers across sectors, see our guide to top dividend stocks to watch in 2025.
How to Evaluate MO for Your Income Portfolio
Use this five-step framework to assess whether Altria's dividend fits your specific situation:
1. Use Adjusted EPS Payout Ratio — Not GAAP
As explained in Section 7, Altria's GAAP payout ratio is periodically distorted by large non-cash impairment charges (JUUL, primarily). Always evaluate Altria's dividend sustainability using the company's stated adjusted EPS payout ratio target (~80%) and free cash flow generation — not the GAAP EPS-based ratio. Altria clearly discloses adjusted EPS in quarterly earnings releases, allowing direct comparison to the dividend rate.
2. Assess Your Tolerance for Secular Decline Risk
Altria's dividend sustainability is not primarily an earnings concern for the next 5 years — it's a structural question: can Altria transition its business model fast enough as cigarette demand erodes? Track annual cigarette shipment volume decline (typically 4–7% per year industrywide) against Marlboro pricing increases and smokeless product revenue growth. A widening gap between volume decline and pricing power is the early warning signal for future dividend pressure.
3. Monitor NJOY Integration and "on!" Pouch Growth
Altria acquired NJOY e-vapor for approximately $2.75 billion in 2023 — its replacement bet for the failed JUUL investment. NJOY holds FDA marketing authorization for its NJOY ACE device. Track NJOY's market share gains in the e-vapor segment and the volume growth trajectory of "on!" nicotine pouches. If smokeless and e-vapor segments can replace cigarette FCF at scale, the long-term dividend is significantly more secure.
4. Understand the "High Yield Warning" Context
A ~6–7% dividend yield is extraordinary for a company of Altria's size and stability — but it also reflects market skepticism about the long-term trajectory. High dividend yield in isolation can indicate either exceptional value or pricing in a future dividend cut. For MO, this debate is ongoing. Income investors should treat the current yield as a feature of the risk/reward profile, not as a free lunch: the yield is elevated partly because the market prices in long-term structural uncertainty.
5. Consider Tax Treatment and Total Return Expectations
Altria's dividends generally qualify as qualified dividends for U.S. individual investors meeting the holding period requirement (60+ days surrounding the ex-dividend date), taxed at preferential 0% / 15% / 20% rates. Given MO's total return profile is heavily weighted toward dividend income (capital price appreciation has been modest over the past decade), understanding after-tax yield efficiency is especially important for taxable investors. For a full primer on dividend taxation, see our guide to dividends and how they work.
Risks & Downsides of Owning MO for Dividends
- Secular cigarette volume decline: U.S. cigarette volumes have declined every year for decades and that trend shows no signs of reversing. While Altria offsets this through pricing, the pricing lever has limits. A sudden acceleration in volume decline (e.g., driven by FDA menthol bans or other regulatory action) could compress FCF faster than anticipated.
- Capital allocation history — JUUL: Altria's $12.8 billion JUUL investment was one of the largest capital misallocations in recent corporate history. The investment was eventually worth a fraction of what was paid. While Altria has pivoted to NJOY, income investors should weigh this track record when evaluating how management might allocate future free cash flow.
- Regulatory and litigation risk: The tobacco industry operates under constant regulatory oversight. The FDA retains authority to prohibit menthol cigarettes (a decision that remains politically and legally contested), impose graphic warning requirements, and restrict nicotine levels in cigarettes. Ongoing litigation also represents a material liability. Any major adverse regulatory decision could materially impair Altria's FCF and dividend capacity.
- ESG and institutional exclusion: Many institutional investors, pension funds, and ESG-screened ETFs explicitly exclude tobacco stocks. This structural exclusion limits the universe of buyers for MO shares over time and may contribute to a persistent valuation discount versus the broader market — sustaining the high yield in part through price underperformance.
- Smokeless transition uncertainty: The growth of "on!" pouches and NJOY's ACE devices are promising, but oral nicotine and e-vapor are competitive segments (Zyn by Swedish Match/PM dominates the pouch market) with ongoing regulatory uncertainty. If smokeless products cannot scale to replace cigarette economics, Altria faces a long-term FCF decline with no alternative revenue engine.
- Dividend growth rate compression: Even if Altria maintains its dividend without a cut, rising payout ratio pressure from declining earnings volume means dividend growth is likely to remain subdued (~4% per year or less). Investors expecting the growth rate of 2015–2018 (when increases of 8–14% were common) should recalibrate expectations.
For investors concerned about tobacco sector concentration, consider exploring diversified income options in our dividend ETF guide.
Summary & Key Takeaways
- ✅ Altria (MO) pays $1.06 per share quarterly (~$4.24 annualized), delivering a trailing yield of approximately 6%–7% — one of the highest large-cap yields in the U.S. equity market.
- ✅ MO holds Dividend King status with 55+ consecutive years of annual dividend increases — one of fewer than 50 U.S. companies with this designation, exceptional in any sector.
- ✅ The 2008 Philip Morris International spinoff reduced Altria's per-share dollar amount but is credited by major dividend databases as a proportionate corporate restructuring rather than a discretionary cut — the combined MO + PM payout preserved shareholder income.
- ✅ Altria's adjusted EPS payout ratio (~78–82%) and strong operating cash flow (~$8–10B annually) confirm the dividend is financially supported in the medium term.
- ✅ The NJOY acquisition (2023) and "on!" nicotine pouch growth represent Altria's clearest current path to replacing combustible cigarette economics in the smokeless era.
- ⚠️ The GAAP payout ratio exceeding 100% in some years is misleading — largely caused by non-cash JUUL impairment charges, not an actual shortfall in cash to fund dividends.
- ⚠️ The 6–7% yield is not "free income" — it reflects genuine market skepticism about Altria's long-term trajectory as cigarette volumes decline. A high yield can signal opportunity or future risk; the distinction requires ongoing monitoring.
- ⚠️ The $12.8B JUUL investment writedown remains a cautionary note on Altria's capital allocation track record outside its core tobacco business.
- ⚠️ Regulatory risks are structural — FDA menthol decisions, nicotine regulation, and ongoing tobacco litigation represent continuously evolving threats that income investors must monitor on a multi-year basis.
Frequently Asked Questions
Altria currently pays $1.06 per share per quarter, equating to approximately $4.24 per share annually at the current declared rate. This represents an increase from the prior $1.02 quarterly rate, which was in effect through Q1 2025. At MO share prices in the $55–$70 range (approximate as of early 2026), this generates a trailing yield of approximately 6%–7%. Always verify the current declared quarterly dividend at investor.altria.com, as exact amounts are confirmed by Altria's Board of Directors each quarter.
Altria qualifies for both designations. It is a Dividend Aristocrat (S&P 500 member with 25+ consecutive years of increases) and a Dividend King (50+ consecutive years of increases). With 55+ consecutive annual increases as of 2025, Altria is one of fewer than 50 U.S. companies to have attained Dividend King status. It is worth noting that some analysts debate whether the 2008 Philip Morris International spinoff should reset the streak — but most dividend databases and Altria itself credit the full history toward the consecutive increase count.
Altria's GAAP payout ratio has appeared above 100% in years when the company recorded large non-cash impairment charges — primarily the writedown of its $12.8 billion stake in JUUL Labs. These charges dramatically reduced GAAP EPS in affected periods but do not represent cash flowing out of the company. Altria's adjusted (non-GAAP) payout ratio — which excludes these non-cash items — has historically been approximately 78–82%, which is sustainable given the company's strong operating cash flow. Always use Altria's adjusted EPS figures when assessing dividend sustainability, not the GAAP-based ratio.
Altria spun off its international tobacco operations as Philip Morris International (NYSE: PM) on March 28, 2008. Each Altria shareholder received one PM share for every MO share held. After the spinoff, Altria became a purely U.S.-focused tobacco company while PM operates internationally. Altria's per-share dollar dividend was reduced post-spinoff to reflect the smaller business retained, but the combined MO + PM dividends preserved shareholder income. Most dividend databases, including S&P's Aristocrat list, credit Altria's pre-2008 history toward its consecutive increase streak.
In December 2018, Altria acquired a 35% stake in JUUL Labs for $12.8 billion, valuing JUUL at approximately $38 billion. The investment quickly turned disastrous: regulatory pressure, FDA restrictions, and JUUL's own financial and legal troubles caused Altria to write down the stake repeatedly. By 2022, the investment was worth approximately 5% of its original value. Altria eventually pivoted away from JUUL and acquired NJOY Holdings in 2023 for approximately $2.75 billion as its current e-vapor platform. The JUUL episode remains one of the most significant capital allocation failures in Altria's history.
Altria's primary mechanism for sustaining dividends despite declining cigarette volumes is pricing power — raising Marlboro prices faster than the rate of volume decline, which partially offsets revenue compression. The tobacco business is also capital-light, generating strong free cash flow even as revenues grow slowly or contract. Additionally, Altria is actively expanding in oral nicotine pouches ("on!" brand) and e-vapor (NJOY) — products where volume is growing rather than declining. The degree to which these smokeless segments can ultimately replace combustible cigarette FCF is the key long-term sustainability question for the dividend.
Altria's ex-dividend dates typically fall in March, June, September, and December of each year. For 2025, the declared ex-dates were approximately March 25 (Q1), June 16 (Q2), September 15 (Q3), and December 26 (Q4). To receive any quarterly dividend, you must own MO shares before the ex-dividend date — T+1 settlement means purchasing the day before the ex-date is sufficient. For the exact upcoming ex-dividend date, always verify at investor.altria.com or in your brokerage's dividend calendar, as Altria declares each quarterly dividend a few weeks in advance.
Buying a stock solely for its high dividend yield — without understanding the underlying business risks — is a common mistake. Altria's ~6–7% yield is elevated partly because the market prices in genuine long-term uncertainty about the tobacco industry's future. A high yield can signal either exceptional income value or an elevated risk of future dividend reduction — and for MO, both possibilities exist. Before investing, consider whether you are comfortable with secular cigarette volume decline, potential regulatory disruptions, the JUUL capital allocation history, and the ongoing smokeless transition. Dividend investing involves risk, including the possibility of dividend reductions — consult a qualified financial advisor for personalized guidance.